medpundit |
||
|
Monday, December 27, 2004UPDATE: And The Wall Street Journal weighs in, too: One of the most frustrating things about the latest news on painkillers is that almost none of the people reporting it understand the concept of relative risk--i.e., that a doubling of adverse events like heart attacks still doesn't mean that event is very likely. A doubled risk might well be a chance worth taking, especially if the baseline risk is low to begin with and the drug's benefits are significant for the patient in question. All of us implicitly accept this proposition with chemotherapy, for example, which poisons the entire body to kill a few cancer cells. posted by Sydney on 12/27/2004 06:12:00 AM 0 comments 0 Comments: |
|